Use of fibrin sealant in thermal injury

Victoria McGill, Areta Kowal-Vern, Martin Lee, David G Greenhalgh, Edward Gomperts, Gordon Bray, Richard L. Gamelli

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Fibrin glue is hemostatic in skin grafting and other therapeutic situations. This prospective, open-labeled comparative study involved thermally injured patients: 34 patients received fibrin sealant (FS) and 61 did not, at Loyola University Medical Center, Maywood, Illinois, and Shriners Burn Institute, Cincinnati, Ohio. FS-treated patients were 23.6 ± 16.8 years old, versus 20.8 ± 16.8 years for controls. The percentage of total body surface areas burn was 10.0% ± 4.5% in the study patients versus 10.9% ± 7.9% in the controls. The FS group did not receive packed red blood cell transfusions, albumin infusion, or topical bovine thrombin (TBT). The control group received 1.56 ± 2.1 units of packed red blood cells, 186 ± 194 ml 5% albumin, and TBT (20,000 units) 2.6 ± 0.8 kits during excision and grafting procedures. The estimated blood loss/graft ratio was 0.50 ± 0.30 ml/cm2 (median = 0.46) for the study group versus 0.98 ± 2.4 ml/cm2 (median = 0.56) for the control group (p = 0.14); for patients more than 16 years of age, this difference was significant (p = 0.03). FS may be a viable alternative to standard hemostatic techniques, because it reduced the need for blood transfusion, alloantigen exposures and blood-borne viral infection risk. FS also eliminated the need for TBT and epinephrine, did not have an adverse impact on the surgical outcome, and tended to improve the cost differential.

Original languageEnglish (US)
Pages (from-to)429-434
Number of pages6
JournalJournal of Burn Care and Rehabilitation
Volume18
Issue number5
DOIs
StatePublished - Sep 1997
Externally publishedYes

Fingerprint

Fibrin Tissue Adhesive
Hot Temperature
Wounds and Injuries
Thrombin
Albumins
Hemostatic Techniques
Erythrocyte Transfusion
Control Groups
Skin Transplantation
Isoantigens
Body Surface Area
Hemostatics
Virus Diseases
Blood Transfusion
Epinephrine
Erythrocytes
Transplants
Costs and Cost Analysis

ASJC Scopus subject areas

  • Rehabilitation
  • Surgery
  • Nursing(all)
  • Health Professions(all)
  • Emergency Medicine

Cite this

McGill, V., Kowal-Vern, A., Lee, M., Greenhalgh, D. G., Gomperts, E., Bray, G., & Gamelli, R. L. (1997). Use of fibrin sealant in thermal injury. Journal of Burn Care and Rehabilitation, 18(5), 429-434. https://doi.org/10.1097/00004630-199709000-00011

Use of fibrin sealant in thermal injury. / McGill, Victoria; Kowal-Vern, Areta; Lee, Martin; Greenhalgh, David G; Gomperts, Edward; Bray, Gordon; Gamelli, Richard L.

In: Journal of Burn Care and Rehabilitation, Vol. 18, No. 5, 09.1997, p. 429-434.

Research output: Contribution to journalArticle

McGill, V, Kowal-Vern, A, Lee, M, Greenhalgh, DG, Gomperts, E, Bray, G & Gamelli, RL 1997, 'Use of fibrin sealant in thermal injury', Journal of Burn Care and Rehabilitation, vol. 18, no. 5, pp. 429-434. https://doi.org/10.1097/00004630-199709000-00011
McGill, Victoria ; Kowal-Vern, Areta ; Lee, Martin ; Greenhalgh, David G ; Gomperts, Edward ; Bray, Gordon ; Gamelli, Richard L. / Use of fibrin sealant in thermal injury. In: Journal of Burn Care and Rehabilitation. 1997 ; Vol. 18, No. 5. pp. 429-434.
@article{2bdcc6c251324cddbef1b91db9396c78,
title = "Use of fibrin sealant in thermal injury",
abstract = "Fibrin glue is hemostatic in skin grafting and other therapeutic situations. This prospective, open-labeled comparative study involved thermally injured patients: 34 patients received fibrin sealant (FS) and 61 did not, at Loyola University Medical Center, Maywood, Illinois, and Shriners Burn Institute, Cincinnati, Ohio. FS-treated patients were 23.6 ± 16.8 years old, versus 20.8 ± 16.8 years for controls. The percentage of total body surface areas burn was 10.0{\%} ± 4.5{\%} in the study patients versus 10.9{\%} ± 7.9{\%} in the controls. The FS group did not receive packed red blood cell transfusions, albumin infusion, or topical bovine thrombin (TBT). The control group received 1.56 ± 2.1 units of packed red blood cells, 186 ± 194 ml 5{\%} albumin, and TBT (20,000 units) 2.6 ± 0.8 kits during excision and grafting procedures. The estimated blood loss/graft ratio was 0.50 ± 0.30 ml/cm2 (median = 0.46) for the study group versus 0.98 ± 2.4 ml/cm2 (median = 0.56) for the control group (p = 0.14); for patients more than 16 years of age, this difference was significant (p = 0.03). FS may be a viable alternative to standard hemostatic techniques, because it reduced the need for blood transfusion, alloantigen exposures and blood-borne viral infection risk. FS also eliminated the need for TBT and epinephrine, did not have an adverse impact on the surgical outcome, and tended to improve the cost differential.",
author = "Victoria McGill and Areta Kowal-Vern and Martin Lee and Greenhalgh, {David G} and Edward Gomperts and Gordon Bray and Gamelli, {Richard L.}",
year = "1997",
month = "9",
doi = "10.1097/00004630-199709000-00011",
language = "English (US)",
volume = "18",
pages = "429--434",
journal = "Journal of Burn Care and Research",
issn = "1559-047X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Use of fibrin sealant in thermal injury

AU - McGill, Victoria

AU - Kowal-Vern, Areta

AU - Lee, Martin

AU - Greenhalgh, David G

AU - Gomperts, Edward

AU - Bray, Gordon

AU - Gamelli, Richard L.

PY - 1997/9

Y1 - 1997/9

N2 - Fibrin glue is hemostatic in skin grafting and other therapeutic situations. This prospective, open-labeled comparative study involved thermally injured patients: 34 patients received fibrin sealant (FS) and 61 did not, at Loyola University Medical Center, Maywood, Illinois, and Shriners Burn Institute, Cincinnati, Ohio. FS-treated patients were 23.6 ± 16.8 years old, versus 20.8 ± 16.8 years for controls. The percentage of total body surface areas burn was 10.0% ± 4.5% in the study patients versus 10.9% ± 7.9% in the controls. The FS group did not receive packed red blood cell transfusions, albumin infusion, or topical bovine thrombin (TBT). The control group received 1.56 ± 2.1 units of packed red blood cells, 186 ± 194 ml 5% albumin, and TBT (20,000 units) 2.6 ± 0.8 kits during excision and grafting procedures. The estimated blood loss/graft ratio was 0.50 ± 0.30 ml/cm2 (median = 0.46) for the study group versus 0.98 ± 2.4 ml/cm2 (median = 0.56) for the control group (p = 0.14); for patients more than 16 years of age, this difference was significant (p = 0.03). FS may be a viable alternative to standard hemostatic techniques, because it reduced the need for blood transfusion, alloantigen exposures and blood-borne viral infection risk. FS also eliminated the need for TBT and epinephrine, did not have an adverse impact on the surgical outcome, and tended to improve the cost differential.

AB - Fibrin glue is hemostatic in skin grafting and other therapeutic situations. This prospective, open-labeled comparative study involved thermally injured patients: 34 patients received fibrin sealant (FS) and 61 did not, at Loyola University Medical Center, Maywood, Illinois, and Shriners Burn Institute, Cincinnati, Ohio. FS-treated patients were 23.6 ± 16.8 years old, versus 20.8 ± 16.8 years for controls. The percentage of total body surface areas burn was 10.0% ± 4.5% in the study patients versus 10.9% ± 7.9% in the controls. The FS group did not receive packed red blood cell transfusions, albumin infusion, or topical bovine thrombin (TBT). The control group received 1.56 ± 2.1 units of packed red blood cells, 186 ± 194 ml 5% albumin, and TBT (20,000 units) 2.6 ± 0.8 kits during excision and grafting procedures. The estimated blood loss/graft ratio was 0.50 ± 0.30 ml/cm2 (median = 0.46) for the study group versus 0.98 ± 2.4 ml/cm2 (median = 0.56) for the control group (p = 0.14); for patients more than 16 years of age, this difference was significant (p = 0.03). FS may be a viable alternative to standard hemostatic techniques, because it reduced the need for blood transfusion, alloantigen exposures and blood-borne viral infection risk. FS also eliminated the need for TBT and epinephrine, did not have an adverse impact on the surgical outcome, and tended to improve the cost differential.

UR - http://www.scopus.com/inward/record.url?scp=0030961177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030961177&partnerID=8YFLogxK

U2 - 10.1097/00004630-199709000-00011

DO - 10.1097/00004630-199709000-00011

M3 - Article

VL - 18

SP - 429

EP - 434

JO - Journal of Burn Care and Research

JF - Journal of Burn Care and Research

SN - 1559-047X

IS - 5

ER -